Judo Bio

Seeded by Atlas Venture and The Column Group and in stealth-mode, Judo Bio is pioneering development of a new class of precision therapeutics targeting specific cell populations, a platform that will ultimately have the potential to address significant unmet medical need in genetic diseases and beyond. Leveraging our innovative receptor targeting approach, we are working to build a pipeline that will benefit patients impacted by both common and rare disease. Enabled by a network of high caliber experts and internal talent, we are thoughtfully building a team of passionate, innovative, and energetic scientific champions to discover and develop therapeutics that have the potential to change the lives of patients and families.